Francis A. Mhimbira
Dar Es Salaam, United Republic of Tanzania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: February 19, 2026
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB.
Journal: The Journal of antimicrobial chemotherapy
Published: March 03, 2025
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
Facilitators and barriers in implementation of active TB drug safety monitoring and management (aDSM) in programmatic management of drug resistance TB in Dar es Salaam region.
Journal: PloS one
Published: November 16, 2022
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis.
Journal: Trials
Published: September 01, 2022
Ultrasononography in Managing Extrapulmonary Tuberculosis: A Randomized, Controlled, Parallel, Superiority, Open-Label Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 19, 2022
Symptoms and functional limitations related to respiratory health and carbon monoxide poisoning in Tanzania: a cross sectional study.
Journal: Environmental health : a global access science source
Published: September 21, 2021
Mortality and associated factors among adult patients on tuberculosis treatment in Tanzania: A retrospective cohort study.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: August 06, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: March 25, 2021
The Sputum Microbiome in Pulmonary Tuberculosis and Its Association With Disease Manifestations: A Cross-Sectional Study.
Journal: Frontiers in microbiology
Published: November 25, 2020
Xpert® MTB/RIF assay testing on stool for the diagnosis of paediatric pulmonary TB in Tanzania.
Journal: Public health action
Published: October 13, 2020
Last Updated: 09/26/2026